Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate.
Palacios, Santiago
Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate. [electronic resource] - The Journal of clinical endocrinology and metabolism Mar 2015 - E487-92 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1945-7197
10.1210/jc.2014-3594 doi
Aged
Antibodies, Monoclonal, Humanized--therapeutic use
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Denosumab
Diphosphonates--therapeutic use
Drug Substitution
Etidronic Acid--analogs & derivatives
Female
Humans
Ibandronic Acid
Middle Aged
Osteoporosis, Postmenopausal--drug therapy
Patient Satisfaction
Risedronic Acid
Treatment Outcome
Assessment of Medication Adherence
Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate. [electronic resource] - The Journal of clinical endocrinology and metabolism Mar 2015 - E487-92 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1945-7197
10.1210/jc.2014-3594 doi
Aged
Antibodies, Monoclonal, Humanized--therapeutic use
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Denosumab
Diphosphonates--therapeutic use
Drug Substitution
Etidronic Acid--analogs & derivatives
Female
Humans
Ibandronic Acid
Middle Aged
Osteoporosis, Postmenopausal--drug therapy
Patient Satisfaction
Risedronic Acid
Treatment Outcome
Assessment of Medication Adherence